| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9936719 | The American Journal of Cardiology | 2005 | 4 Pages |
Abstract
The comparison of treatment effect and co-morbidity between the genders in the Valsartan Heart Failure Trial showed equal benefit of treatment in men and women. Co-morbidities, such as diabetes and coronary artery disease, increased nonfatal cardiac morbidity more in women than in men.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Silja K. MD, PhD, Lawrence MD, Nora BSc, Liselotte MD, Monika MD, Allen PhD, Margaret Forney PhD, Nancy MD, for the Val-HeFT Study Investigators for the Val-HeFT Study Investigators,